Targeting B-cell receptor signaling kinases in chronic lymphocytic leukemia: the promise of entospletinib
about
Targeting of B-cell receptor signalling in B-cell malignancies.High SYK Expression Drives Constitutive Activation of CD21low B Cells.Syk inhibitors in clinical development for hematological malignancies.Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies
P2860
Targeting B-cell receptor signaling kinases in chronic lymphocytic leukemia: the promise of entospletinib
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Targeting B-cell receptor sign ...... : the promise of entospletinib
@ast
Targeting B-cell receptor sign ...... : the promise of entospletinib
@en
Targeting B-cell receptor sign ...... : the promise of entospletinib
@nl
type
label
Targeting B-cell receptor sign ...... : the promise of entospletinib
@ast
Targeting B-cell receptor sign ...... : the promise of entospletinib
@en
Targeting B-cell receptor sign ...... : the promise of entospletinib
@nl
prefLabel
Targeting B-cell receptor sign ...... : the promise of entospletinib
@ast
Targeting B-cell receptor sign ...... : the promise of entospletinib
@en
Targeting B-cell receptor sign ...... : the promise of entospletinib
@nl
P2860
P356
P1476
Targeting B-cell receptor sign ...... : the promise of entospletinib
@en
P2093
Jeff Sharman
Julie Di Paolo
P2860
P304
P356
10.1177/2040620716636542
P407
P577
2016-06-01T00:00:00Z